These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25098061)

  • 1. Efficacy of topical clotrimazole in treatment of otomycosis.
    Khan F; Muhammad R; Khan MR; Rehman F; Iqbal J; Khan M; Ullah G
    J Ayub Med Coll Abbottabad; 2013; 25(1-2):78-80. PubMed ID: 25098061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Povidone iodine soaked gelfoam for the treatment of recalcitrant otomycosis - Our experiences at a tertiary care teaching hospital of eastern India.
    Swain SK; Behera IC; Sahu MC; Das A
    J Mycol Med; 2018 Mar; 28(1):122-127. PubMed ID: 29223643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Clotrimazole 1% Solution Compared to Econazole Nitrate 1% + Triamcinolone Acetonide 0.1% Cream in Patient with Otomycosis.
    Mostafa MG; Ahmed S; Islam MR; Rahman MA; Khan L; Alam MM; Ahmed MB
    Mymensingh Med J; 2021 Jul; 30(3):638-643. PubMed ID: 34226449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Various topical antifungal agents in otomycosis, which is the best?
    Jwery AK
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S32-S34. PubMed ID: 35130214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of 3 per cent boric acid in 70 per cent alcohol versus 1 per cent clotrimazole solution in otomycosis patients: a randomised, controlled trial.
    Romsaithong S; Tomanakan K; Tangsawad W; Thanaviratananich S
    J Laryngol Otol; 2016 Sep; 130(9):811-5. PubMed ID: 27477534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of eberconazole 1% otic solution compared to clotrimazole 1% solution in patients with otomycosis.
    de la Paz Cota BR; Cepero Vega PP; Matus Navarrete JJ; Aguado Mulgado GE; Narváez Huerta JJ; Lamadrid Bautista E; Fiscal Chauteco E
    Am J Otolaryngol; 2018; 39(3):307-312. PubMed ID: 29551350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial.
    Jimenez-Garcia L; Celis-Aguilar E; Díaz-Pavón G; Muñoz Estrada V; Castro-Urquizo Á; Hernández-Castillo N; Amaro-Flores E
    Braz J Otorhinolaryngol; 2020; 86(3):300-307. PubMed ID: 30826311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review.
    Viswanatha B; Sumatha D; Vijayashree MS
    Ear Nose Throat J; 2012 Mar; 91(3):114-21. PubMed ID: 22430336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment.
    Mofatteh MR; Naseripour Yazdi Z; Yousefi M; Namaei MH
    Braz J Otorhinolaryngol; 2018; 84(4):404-409. PubMed ID: 28549873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome of otomycosis in Ilorin, Nigeria.
    Ologe FE; Nwabuisi C
    West Afr J Med; 2002; 21(1):34-6. PubMed ID: 12081339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of Locacorten-Vioform and clotrimazole in otomycosis: A systematic review and one-way meta-analysis.
    Herasym K; Bonaparte JP; Kilty S
    Laryngoscope; 2016 Jun; 126(6):1411-9. PubMed ID: 26600419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otomycosis in Shanghai: aetiology, clinical features and therapy.
    Jia X; Liang Q; Chi F; Cao W
    Mycoses; 2012 Sep; 55(5):404-9. PubMed ID: 21999222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Clotrimazole in Prevention of Recurrent Otomycosis.
    Kiakojuri K; Rajabnia R; Mahdavi Omran S; Pournajaf A; Karami M; Taghizadeh Armaki M
    Biomed Res Int; 2019; 2019():5269535. PubMed ID: 31950041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of extemporaneously compounded 1% tetracaine to improve adherence with clotrimazole 1% topical solution in the treatment of ear infection: a case report.
    Kolling WM; McPherson TB; McJunkin JL
    Am J Otolaryngol; 2013; 34(6):757-8. PubMed ID: 23932769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory Aspergillus otomycosis with voriconazole: case series and review.
    Ho HC; Hsiao SH; Lee CY; Tsai CC
    J Laryngol Otol; 2014 Jun; 128(6):547-51. PubMed ID: 24909800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of otomycosis with clotrimazole: results accordingly with the fungus isolated.
    Antunes J; Mendes N; Adónis C; Freire F
    Acta Otolaryngol; 2022; 142(9-12):664-667. PubMed ID: 36128634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
    Pradhan B; Tuladhar NR; Amatya RM
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):384-7. PubMed ID: 12731637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.
    Nemati S; Hassanzadeh R; Khajeh Jahromi S; Delkhosh Nasrollah Abadi A
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):953-7. PubMed ID: 23595615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of 1% topical voriconazole drops was effective and safe in the treatment of refractory otomycosis without tympanic membrane perforation.
    Zhang S; Jin M; Hu S; Zhang Y; Zhou G
    Ann Otol Rhinol Laryngol; 2021 Mar; 130(3):273-279. PubMed ID: 32772544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of topical isoconazole nitrate in the treatment of otomycosis.
    Gülüstan F; Abakay MA; Demir E
    Am J Otolaryngol; 2021; 42(4):102961. PubMed ID: 33621764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.